• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视黄醇和视黄醇结合蛋白通过形成视黄醇转运复合物稳定转甲状腺素蛋白。

Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex.

机构信息

Department of Chemistry, Oxford University, United Kingdom.

出版信息

ACS Chem Biol. 2010 Dec 17;5(12):1137-46. doi: 10.1021/cb100144v. Epub 2010 Oct 7.

DOI:10.1021/cb100144v
PMID:20845945
Abstract

Transthyretin (TTR) is a plasma hormone carrier protein associated with hereditary and senile forms of systemic amyloid disease, wherein slow tetramer disassembly is thought to be an obligatory step. Plasma transport of retinol is carried out exclusively by the retinol-binding protein (RBP), through complexation with transthyretin. Using mass spectrometry to examine the subunit exchange dynamics, we find that retinol stabilizes the quaternary structure of transthyretin, through its interactions with RBP, reducing the rate of transthyretin disassembly ∼17-fold compared to apoTTR. In the absence of retinol but in the presence of RBP, transthyretin is only marginally stabilized with the rate of disassembly reduced ∼two-fold with respect to apoTTR. Surprisingly, we found two retinoids that stabilize transthyretin directly, in the absence of RBP, whereas retinol itself requires RBP in order to stabilize transthyretin. Our results demonstrate new roles for RBP and retinoids as stabilizers of transthyretin.

摘要

转甲状腺素蛋白(TTR)是一种与遗传性和老年性系统性淀粉样变性疾病相关的血浆激素载体蛋白,其中缓慢的四聚体解体被认为是一个必需的步骤。视黄醇的血浆转运完全由视黄醇结合蛋白(RBP)通过与转甲状腺素蛋白的复合物来完成。通过质谱分析研究亚基交换动力学,我们发现视黄醇通过与 RBP 的相互作用稳定转甲状腺素蛋白的四级结构,使转甲状腺素蛋白的解体速度比apoTTR 降低约 17 倍。在没有视黄醇但存在 RBP 的情况下,转甲状腺素蛋白仅得到轻微稳定,其解体速度比 apoTTR 降低约 2 倍。令人惊讶的是,我们发现了两种视黄醇衍生物,它们在没有 RBP 的情况下直接稳定转甲状腺素蛋白,而视黄醇本身需要 RBP 才能稳定转甲状腺素蛋白。我们的结果表明,RBP 和视黄醇衍生物在稳定转甲状腺素蛋白方面具有新的作用。

相似文献

1
Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex.视黄醇和视黄醇结合蛋白通过形成视黄醇转运复合物稳定转甲状腺素蛋白。
ACS Chem Biol. 2010 Dec 17;5(12):1137-46. doi: 10.1021/cb100144v. Epub 2010 Oct 7.
2
Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.血浆视黄醇结合蛋白:结构及其与视黄醇、类视黄醇和甲状腺素转运蛋白的相互作用
Vitam Horm. 2004;69:271-95. doi: 10.1016/S0083-6729(04)69010-8.
3
The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP.人视黄醇结合蛋白(RBP)与其载体蛋白甲状腺素转运蛋白的结构揭示了RBP羧基末端的一种相互作用。
Biochemistry. 1999 Mar 2;38(9):2647-53. doi: 10.1021/bi982291i.
4
Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.血浆视黄醇结合蛋白、甲状腺素转运蛋白及其配体之间的相互作用:对维生素A稳态和甲状腺素转运蛋白淀粉样变性的影响。
Biochim Biophys Acta. 2004 Dec 1;1703(1):1-9. doi: 10.1016/j.bbapap.2004.09.023.
5
Biochemical basis for retinol deficiency induced by the I41N and G75D mutations in human plasma retinol-binding protein.人血浆视黄醇结合蛋白中I41N和G75D突变导致视黄醇缺乏的生化基础。
Biochem Biophys Res Commun. 2005 Nov 4;336(4):1017-22. doi: 10.1016/j.bbrc.2005.08.227.
6
The interaction between retinol-binding protein and transthyretin analyzed by fluorescence anisotropy.通过荧光各向异性分析视黄醇结合蛋白与甲状腺素转运蛋白之间的相互作用。
Methods Mol Biol. 2010;652:189-207. doi: 10.1007/978-1-60327-325-1_11.
7
Interactions of transthyretin (TTR) and retinol-binding protein (RBP) in the uptake of retinol by primary rat hepatocytes.转甲状腺素蛋白(TTR)与视黄醇结合蛋白(RBP)在原代大鼠肝细胞摄取视黄醇过程中的相互作用。
Exp Cell Res. 1997 Aug 1;234(2):373-8. doi: 10.1006/excr.1997.3642.
8
Characterisation of transthyretin and retinol-binding protein in plasma and cerebrospinal fluid of dogs.犬血浆和脑脊液中转甲状腺素蛋白及视黄醇结合蛋白的特性分析
Vet J. 2006 May;171(3):451-5. doi: 10.1016/j.tvjl.2004.11.017.
9
Assay of retinol-binding protein-transthyretin interaction and techniques to identify competing ligands.视黄醇结合蛋白-甲状腺素转运蛋白相互作用的测定及鉴定竞争性配体的技术
Methods Mol Biol. 2010;652:209-27. doi: 10.1007/978-1-60327-325-1_12.
10
Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.葡萄牙型家族性淀粉样多神经病患者血浆转甲状腺素蛋白(前白蛋白)的研究。
J Lab Clin Med. 1983 Oct;102(4):590-603.

引用本文的文献

1
Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease.转甲状腺素蛋白作为治疗靶点:阿尔茨海默病疾病修饰疗法的未来
Mol Biol Rep. 2025 Apr 8;52(1):370. doi: 10.1007/s11033-025-10485-4.
2
Hereditary Transthyretin Cardiac Amyloidosis With the p.V142I Variant: Mechanistic Insights and Diagnostic Challenges.携带p.V142I变异的遗传性转甲状腺素蛋白心脏淀粉样变性:机制见解与诊断挑战
Circ Heart Fail. 2025 Jun;18(6):e012469. doi: 10.1161/CIRCHEARTFAILURE.124.012469. Epub 2025 Mar 14.
3
Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis.
亚临床转甲状腺素蛋白心脏淀粉样变中的生物标志物
Curr Heart Fail Rep. 2025 Feb 13;22(1):8. doi: 10.1007/s11897-025-00696-y.
4
Association of Dietary Retinol Intake and Serum Neurofilament Light Chain Levels: Results from NHANES 2013-2014.膳食视黄醇摄入量与血清神经丝轻链水平的关联:NHANES 2013-2014 年的结果。
Nutrients. 2024 Jun 4;16(11):1763. doi: 10.3390/nu16111763.
5
Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I carriers in the general population.在普通人群中,V122I 携带者中年人群的循环转甲状腺素蛋白和视黄醇结合蛋白 4 水平。
Amyloid. 2024 Jun;31(2):124-131. doi: 10.1080/13506129.2024.2322479. Epub 2024 Mar 6.
6
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy.野生型转甲状腺素蛋白淀粉样心肌病的分子机制和新兴疗法。
Heart Fail Rev. 2024 Mar;29(2):511-521. doi: 10.1007/s10741-023-10380-9. Epub 2024 Jan 18.
7
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.台湾心脏病学会2023年心脏淀粉样变诊断与治疗专家共识
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
8
Nutritional Factors: Benefits in Glaucoma and Ophthalmologic Pathologies.营养因素:对青光眼及其他眼科疾病的益处。
Life (Basel). 2023 Apr 30;13(5):1120. doi: 10.3390/life13051120.
9
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.人转甲状腺素蛋白的历程:合成、结构稳定性及分解代谢
Biomedicines. 2022 Aug 6;10(8):1906. doi: 10.3390/biomedicines10081906.
10
Update on Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变相关疾病特异性生物标志物的最新研究进展。
Curr Heart Fail Rep. 2022 Oct;19(5):356-363. doi: 10.1007/s11897-022-00570-1. Epub 2022 Aug 5.